Benefits
Endogenous Nutrient Declining with Age
GG-Gold positioning emphasizes that geranylgeraniol is endogenous nutrient whose levels decline during aging process — replacement supplementation rationale.
Mevalonate Pathway Support
Geranylgeraniol is intermediate in mevalonate pathway — relevant to CoQ10, tocotrienol, vitamin K2 biosynthesis.
Annatto-Derived Natural Source
Sourced from annatto plant (Bixa orellana) — same source as DeltaGold tocotrienols; complementary biological pathway.
Healthy Aging Applications
Replacement of declining nutrient supports healthy aging and mitochondrial function.
Newer Ingredient with Emerging Evidence
GG research is emerging; ARN's specific clinical evaluation establishes evidence base.
Complementary to DeltaGold
ARN's two flagship ingredients (DeltaGold tocotrienols + GG-Gold geranylgeraniol) work in related biological pathways.
Mechanism of action
Mevalonate Pathway Intermediate
Geranylgeraniol is intermediate in mevalonate pathway — same pathway producing cholesterol, CoQ10, vitamin K2, tocotrienols, dolichols.
Protein Prenylation
GG involved in protein prenylation (post-translational modification) of proteins critical for cellular signaling and function.
Cellular Signaling
Modulates cellular signaling pathways relevant to aging and metabolic health.
Statin Interaction Context
Statins inhibit HMG-CoA reductase (mevalonate pathway start); may reduce downstream products including GG; theoretical replacement role.
Clinical trials
ARN clinical evaluation of GG-Gold geranylgeraniol — newer ingredient with emerging clinical evidence.
Adults across applications.
Establishing evidence base for healthy aging applications.